Steward Partners Investment Advisory, LLC Mainz Biomed N.V. Transaction History
Steward Partners Investment Advisory, LLC
- $10.6 Billion
- Q3 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Mainz Biomed N.V. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 29,000 shares of MYNZ stock, worth $7,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,000Holding current value
$7,250% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding MYNZ
# of Institutions
12Shares Held
191KCall Options Held
0Put Options Held
0-
Vontobel Holding Ltd.45KShares$11,2500.0% of portfolio
-
Northern Trust Corp Chicago, IL29.9KShares$7,4830.0% of portfolio
-
Two Sigma Securities, LLC New York, NY23.5KShares$5,8780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA15.2KShares$3,7970.0% of portfolio
-
Jane Street Group, LLC New York, NY14.6KShares$3,6390.0% of portfolio
About MAINZ BIOMED N.V.
- Ticker MYNZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 14,483,000
- Market Cap $3.62M
- Description
- Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments...